News
01-25-2011, 06:11 AM
A new study has found that tamoxifen, an anti-estrogen breast cancer medication, may reduce an individual's risk of death from lung cancer. Published early online in Cancer, a peer-reviewed journal of the American Cancer Society, the study supports the hypothesis that there is a hormonal influence on lung cancer and that estrogen levels play a role in lung cancer patients' prognosis...
More... (http://mnt.to/f/3Qqk)
More... (http://mnt.to/f/3Qqk)